At the MELISA Institute, our expert team of Molecular Epidemiology scientists, work continuously studying and analyzing the causes and effects of the diseases that impact women, especially during pregnancy. Through our statistical data recollection methods, epidemiological information analyses and the use of specialized statistical methods, we are able to understand the causes of morbidity and mortality of women during their fertile years.
Our main programas areas are:
MELISA Institute, was founded to non-invasively investigate pregnancy and very early stages of embryo development looking for ultra-early biomarkers useful to identify diseases during pregnancy (prenatal diagnosis).
In addition, we are interested in developing in utero noninvasive therapeutic options for Trisomy 21 (Down Syndrome) and other genetic or congenital anomalies. We look for preventing or ameliorating associated consequences of this genetic disease.

MELISA Institute, relies on epidemiological research for our commitment with the advance in other important topics such as maternal, embryonic and fetal health determinants, as well as translational medicine initiatives for the wellbeing and health of women in general.